Business Context and Reporting Period
This Form 8-K Current Report was filed by Senseonics Holdings, Inc. on November 28, 2016. The filing reports on a material definitive agreement entered into on that date by Senseonics Incorporated, a wholly-owned subsidiary of the Company.
Key Financial Metrics
This filing does not contain financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The document focuses exclusively on the terms of a commercial agreement.
Material Changes and Agreements
The Company amended its Distribution Agreement with Roche Diagnostics International AG and Roche Diabetes Care GmbH (collectively, "Roche"). Key changes include:
- Exclusive Rights: Roche was granted the exclusive right to market, sell, and distribute the Eversense continuous glucose monitoring system in Europe, the Middle East, and Africa, excluding Sweden, Norway, Denmark, Finland, and Israel.
- Purchase Obligations: Roche is obligated to purchase specified minimum volumes of Eversense components at pre-determined prices, subject to renegotiation under certain circumstances.
- Term Extension: The initial term of the Distribution Agreement was extended through December 31, 2018. The term may be further extended through December 31, 2019, contingent upon agreement regarding minimum purchase requirements for 2019.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance or management commentary regarding future performance. The Company disclaims any obligation to update the information contained in this report except as required by applicable law. The full text of the Amendment is not included in this filing and will be filed as an exhibit to the Annual Report on Form 10-K for the year ending December 31, 2016.
Investor Verification Checklist
- Verify the specific minimum volume purchase requirements and pre-determined pricing terms in the full Amendment text (to be filed in the 2016 Form 10-K).
- Confirm the conditions required to extend the agreement term to December 31, 2019.
- Review the press release dated December 2, 2016 (Exhibit 99.1) for additional context on the strategic partnership.